Last quarter (Q3 2023), Hemostemix's total revenue was C$―, a decrease of ― from the same quarter last year. In Q3, Hemostemix's net income was C$-257.24K. See Hemostemix’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	-	-	-	C$ 0.00	C$ 0.00	C$ 0.00
Cost of Revenue	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-
Operating Expense	C$ 2.71M	C$ 4.63M	C$ 6.66M	C$ 7.47M	C$ 4.70M	C$ 6.42M
Operating Income	C$ -2.71M	C$ -4.63M	C$ -6.66M	C$ -7.47M	C$ -4.70M	C$ -6.42M
Net Non Operating Interest Income Expense	C$ -455.08K	C$ -306.20K	C$ 20.85K	C$ -113.03K	C$ -104.98K	C$ 23.46K
Other Income Expense	C$ -489.72K	C$ -2.21K	C$ 135.17K	C$ -189.11K	C$ -68.64K	C$ 218.17K
Pretax Income	C$ -2.68M	C$ -4.75M	C$ -6.54M	C$ -7.77M	C$ -4.87M	C$ -6.18M
Tax Provision	-	-	C$ -255.78K	C$ 0.00	-	C$ 0.00
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	C$ -2.68M	C$ -4.75M	C$ -6.29M	C$ -7.77M	C$ -4.87M	C$ -6.19M
Basic EPS	C$ -0.03	C$ -0.07	C$ -0.11	C$ -0.24	C$ -0.32	C$ -0.40
Diluted EPS	C$ -0.03	C$ -0.07	C$ -0.11	C$ -0.24	C$ -0.32	C$ -0.40
Basic Average Shares	C$ 311.49M	C$ 69.98M	C$ 57.45M	C$ 32.24M	C$ 15.04M	C$ 14.93M
Diluted Average Shares	C$ 311.49M	C$ 69.98M	C$ 57.45M	C$ 32.24M	C$ 15.04M	C$ 14.93M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	C$ 288.41K	C$ 231.97K	C$ 199.34K
Total Expenses	C$ 2.71M	C$ 4.63M	C$ -6.66M	C$ 7.47M	C$ 4.70M	C$ 6.42M
Net Income From Continuing And Discontinued Operation	C$ -2.68M	C$ -4.75M	C$ -6.29M	C$ -7.77M	C$ -4.87M	C$ -6.19M
Normalized Income	C$ -1.97M	C$ -3.49M	C$ -6.80M	C$ -7.58M	C$ -4.80M	C$ -6.40M
Interest Expense	-	-	-	C$ 106.05K	C$ 104.98K	C$ 0.00
EBIT	C$ -2.22M	C$ -4.44M	C$ -6.53M	C$ -7.66M	C$ -4.76M	C$ -6.18M
EBITDA	C$ -2.22M	C$ -4.44M	C$ -6.53M	C$ -7.66M	C$ -4.76M	C$ -6.18M

Currency in CAD

Hemostemix Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing